Axa S.A. Kura Oncology, Inc. Transaction History

Axa S.A.

  • $32.3 Billion
  • Q3 2024

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$11.23 - $16.9 $18,001 - $27,090
-1,603 Reduced 0.54%
296,184 $3.68 Million
Q3 2022

Feb 14, 2023
SELL
$12.01 - $19.45 $801,811 - $1.3 Million
-66,762 Reduced 18.31%
297,787 $4.07 Million
Q3 2022

Nov 14, 2022
SELL
$12.01 - $19.45 $801,811 - $1.3 Million
-66,762 Reduced 18.31%
297,787 $4.07 Million
Q2 2022

Feb 14, 2023
SELL
$10.71 - $18.33 $75,944 - $129,978
-7,091 Reduced 1.91%
364,549 $6.68 Million
Q2 2022

Aug 15, 2022
SELL
$10.71 - $18.33 $75,944 - $129,978
-7,091 Reduced 1.91%
364,549 $6.68 Million
Q1 2022

Feb 14, 2023
BUY
$11.78 - $16.98 $869,988 - $1.25 Million
73,853 Added 24.8%
371,640 $5.98 Million
Q1 2022

May 13, 2022
BUY
$11.78 - $16.98 $657,182 - $947,280
55,788 Added 17.66%
371,640 $5.98 Million
Q4 2021

Feb 14, 2022
BUY
$12.22 - $19.57 $1.78 Million - $2.85 Million
145,626 Added 85.55%
315,852 $4.42 Million
Q3 2021

Nov 15, 2021
BUY
$15.42 - $21.72 $96,667 - $136,162
6,269 Added 3.82%
170,226 $3.19 Million
Q2 2021

Aug 13, 2021
SELL
$20.85 - $29.88 $259,665 - $372,125
-12,454 Reduced 7.06%
163,957 $3.42 Million
Q1 2021

May 14, 2021
BUY
$24.75 - $39.14 $80,932 - $127,987
3,270 Added 1.89%
176,411 $4.99 Million
Q4 2020

Feb 12, 2021
SELL
$29.0 - $41.62 $1.28 Million - $1.83 Million
-44,022 Reduced 20.27%
173,141 $5.66 Million
Q3 2020

Nov 13, 2020
SELL
$16.3 - $30.64 $1.59 Million - $2.99 Million
-97,708 Reduced 31.03%
217,163 $6.65 Million
Q2 2020

Aug 14, 2020
SELL
$7.95 - $18.81 $88,912 - $210,371
-11,184 Reduced 3.43%
314,871 $5.13 Million
Q1 2020

May 15, 2020
BUY
$6.45 - $14.04 $2.1 Million - $4.58 Million
326,055 New
326,055 $3.24 Million

Others Institutions Holding KURA

# of Institutions
185
Shares Held
81.8M
Call Options Held
42.1K
Put Options Held
34K
View Full List

About Kura Oncology, Inc.

KURA Quotes by TradingView
  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $603M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Axa S.A. Portfolio

Follow Axa S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email